Compumedics Share Price and Company Fundamentals



Price
$0.24
Change
0.005 (2.128%)
52 week
0.15 - 0.445

Last traded: Today at 4:51 AM

Compumedics Limited researches, develops, manufactures, sells, and distributes medical devices in Australia, the Asia Pacific, the Americas, Europe, and the Middle East. It provides sleep diagnostics products, including Grael 4K PSG:EEG amplifiers; Somté PSG; Siesta 802, an ambulatory recording device; Okti; Grael PSG; Grael DC; Somfit/Somfit Pro, a wearable device; TCM5 FLEX Transcutaneous monitor; and Somté, an investigative tool. The company also provides neurology diagnostics, such as ONsight A.V.S. for monitoring patient's home ambulatory studies; Grael 4K PSG:EEG amplifiers; Grael 4K-EEG amplifiers; Grael LT EEG System amplifiers; Neuvo 64-512 Channel LTM EEG monitoring systems; Xegis Forte EMG/EP; and Xegis G:NEO 2 Channel EMG/EP systems. In addition, it offers software products, such as Profusion Sleep software suite; Profusion EEG Software; Profusion neXus 360, a web-based patient data and lab management system that provides integrated hardware and software solutions for sleep and neurology clinics; Multi-Modal Neuroimaging Suite; Profusion neXus Laboratory Management System to optimize administrative and operational workflow needs of diagnostic and research laboratories; Profusion neXus Scheduler for planning for staff and time; and HD Digital Video, a plug-in software module to add synchronized digital video capabilities to sleep and EEG systems, as well as ECG Free, Profusion Plus, Siesta extended battery pack, summit IP, and persyst software products. Further, the company provides magnetoencephalography systems; brain research technologies; pharmaceutical clinical trials and research services; accessories; and a range of consumables and supplies for diagnostic and research solutions. The company was incorporated in 1987 and is headquartered in Abbotsford, Australia. Compumedics Limited operates as a subsidiary of D & DJ Burton Holdings Pty Ltd.

Key Metrics

PE ratio

30.62

PB ratio

1.84

Dividend yield

0.00%

Beta

1.16

Market cap

-

Enterprise value

-

Company profile

Primary activitiesDevelopment and commercialisation of technology in computer based patient monitoring and diagnostic systems.
Industry / SectorMedical Devices / Healthcare
Full time employees135
Websitehttps://www.compumedics.com.au
Mailing address30-40 Flockhart Street Abbotsford VIC 3067 Australia
Phone / Fax61 3 8420 7300 / 61 3 8420 7399
Share registryAUTOMIC REGISTRY SERVICES

Dividends

More: Compumedics Dividend history, yield and payout ratio

Dividend yield

0.00%

Dividend amount

$0.00

Payout ratio

0.00%

Compumedics paid $0.00 dividend and the ex-dividend date was 23 Nov 2004.The dividend payout ratio is 0.00%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.CMP dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.

CMP's forward dividend amount is $ and the forward dividend yield is . A forward dividend yield is the percentage of a company's current stock price that it expects to pay out as dividends over a certain time period, generally 12 months. Forward dividend yields are generally used in circumstances where the yield is predictable based on past instances. If not, trailing yields, which indicate the same value over the previous 12 months, are used.

Company Executives

As of Oct 2022, following are the company executives and directors listed on Compumedics.

NameTitleAgeTotal Pay
Dr. David Burton Ph.D.Founder, Exec. Chairman, CEO & Member of Medical Advisory Board62243.69k
Mr. David Francis LawsonCFO, Company Sec. & Exec. Director56274.77k
Mr. Warwick FreemanChief Technology Officer256.78k
Mr. Christoph WitteGen. Managing of Director DWL Compumedics Germany GmbH388.12k
Dr. Kerry Trent HubickLegal Counsel and Trademark, Patent & Gen. Legal Attorney
Dr. Curtis PontonChief Scientist of Neuroscan & VP
Mr. Paul SpoonerBus. Director of EMEA

Profitability and management effectiveness

Profit margin

3.59%

Operating margin

2.61%

Return on assets

1.54%

Return on equity

5.93%

Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.

The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.

Valuation and Trading Info

The market capitalization of Compumedics is and its enterprise value is .

The CMP's stocks Beta value is 1.16 making it 16% more volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.

Companies similar to Compumedics (CMP)

Compumedics (ASX:CMP) Frequently Asked Questions

1. What is Compumedics's Stock Symbol?

Compumedics trades on ASX under the ticker symbol "CMP".

2. What is Compumedics's stock price today?

One share of CMP stock can currently be purchased for approximately $0.24.

3. How can I contact Compumedics?

Compumedics's mailing address is 30-40 Flockhart Street Abbotsford VIC 3067 Australia. The company can be reached via phone at 61 3 8420 7300.

4. What is Compumedics's official website?

The official website of Compumedics is https://www.compumedics.com.au.

5. Which share registry manages Compumedics's stock?

Compumedics's stock is managed by AUTOMIC REGISTRY SERVICES.